Five things for pharma marketers to know: Friday, November 17, 2017

FDA approves Genentech's hemophilia drug; former Insys CEO pleads not guilty to bribery charges; federal jury rules in favor of Endo in Testim lawsuit

Lions Health to remain segregated after Cannes revamp

Lions Health to remain segregated after Cannes revamp

Lions Health still stands as a separate two-day event, despite a sweeping revamp of the Cannes Lions festival, disappointing some who decried its lack of full integration within the larger program.

Drugmakers and celebrities partner to raise diabetes awareness

Drugmakers and celebrities partner to raise diabetes awareness

Celebrities such as Angela Bassett and Mike Golic share their personal experiences about diabetes.

Centers for Medicare and Medicaid Services puts $900m IDIQ up for bid

Centers for Medicare and Medicaid Services puts $900m IDIQ up for bid

Ketchum, Ogilvy, Porter Novelli, Weber Shandwick, and FleishmanHillard are among the firms that have been awarded past Centers for Medicare and Medicaid Services IDIQ accounts.

Five things for pharma marketers to know: Thursday, November 16, 2017

Five things for pharma marketers to know: Thursday, November 16, 2017

Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson's trial

Cut-down Cannes 'saluted' by Publicis despite pull-out, as others give more cautious welcome

Cut-down Cannes 'saluted' by Publicis despite pull-out, as others give more cautious welcome

French holding company Publicis has welcomed the raft of changes announced to the Cannes Lions festival Monday, while others have given it a more cautious welcome.

Five things for pharma marketers to know: Wednesday, November 15, 2017

Five things for pharma marketers to know: Wednesday, November 15, 2017

FDA approves AstraZeneca asthma drug; Senate tax reform bill would repeal Obamacare mandate; J&J drops Remicade biosimilar lawsuit

Five things for pharma marketers to know: Tuesday, November 14, 2017

Five things for pharma marketers to know: Tuesday, November 14, 2017

FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs

Five things for pharma marketers to know: Monday, November 13, 2017

Five things for pharma marketers to know: Monday, November 13, 2017

Dynavax receives FDA approval for hepatitis-B vaccine; Novartis strikes R&D deal with gene-editing startup; White House nominates new HHS head

Edelman health veteran Donna Duncan joins W2O Chicago

Edelman health veteran Donna Duncan joins W2O Chicago

W2O's Windy City office has added three health and analytics leaders over the past six months.

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

Get America Covered is working to encourage consumers to sign up for coverage through the Affordable Care Act.

Five things for pharma marketers to know: Friday, November 10, 2017

Five things for pharma marketers to know: Friday, November 10, 2017

AstraZeneca sales fall on generic competition; Anthem broadens access for Duchenne muscular dystrophy drug; researchers are developing new biopsy techniques

Five things for pharma marketers to know: Thursday, November 9, 2017

Five things for pharma marketers to know: Thursday, November 9, 2017

GSK hires Google biotech exec to lead R&D; Merck gets FDA-approval for CMV therapy; ex-Lilly exec reportedly top HHS secretary pick

Omnicom promotes Biolumina and H&S presidents to CEO

Omnicom promotes Biolumina and H&S presidents to CEO

Ty Curran, previously CEO of the sister agencies, will serve as chairman in 2018.

Armed with predictive analytics, PBMs push adherence as a stand-in for outcomes

Armed with predictive analytics, PBMs push adherence as a stand-in for outcomes

Pharmacy benefit managers are increasingly measuring a patient's outcome in the context of adherence.

Five things for pharma marketers to know: Wednesday, November 8, 2017

Five things for pharma marketers to know: Wednesday, November 8, 2017

FDA to change Risk Evaluation Mitigation Strategies to prevent delayed generic approvals; Ohio rejects drug-price measure; Aetna CEO wants to improve in-person pharmacy experience

Limits on pharma payments to doctors back on policy menu

Limits on pharma payments to doctors back on policy menu

A mini wave of state-level rule-making has thrust the issue of restrictions on pharma payments to medical professionals back into the spotlight.

Five things for pharma marketers to know: Tuesday, November 7, 2017

Five things for pharma marketers to know: Tuesday, November 7, 2017

Senator investigates Alkermes' opioid-marketing tactics; FDA approves Roche cancer drugs; CVS to launch next-day delivery nationwide

CDC tells opioid addiction stories with message: 'It only takes a little to lose a lot'

CDC tells opioid addiction stories with message: 'It only takes a little to lose a lot'

The CDC has launched the first wave of its awareness campaign about prescription opioids.